Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer

NCT04298983 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Abemaciclib efficacy

Conditions

Prostate Cancer

Interventions

DRUG: Abemaciclib 150 MG by mouth twice daily
DRUG: Androgen deprivation therapy (ADT)
RADIATION: Radiation Therapy

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]